Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $1,810 - $2,148
-45 Reduced 0.23%
19,825 $863,000
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $101,088 - $117,806
2,600 Added 15.06%
19,870 $876,000
Q3 2021

Nov 15, 2021

SELL
$38.79 - $43.16 $26,377 - $29,348
-680 Reduced 3.79%
17,270 $659,000
Q2 2021

Aug 16, 2021

SELL
$36.52 - $41.46 $25,600 - $29,063
-701 Reduced 3.76%
17,950 $714,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $33,241 - $38,809
-970 Reduced 4.94%
18,651 $665,000
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $68,957 - $80,838
-2,024 Reduced 9.35%
19,621 $722,000
Q3 2020

Nov 12, 2020

SELL
$38.11 - $42.99 $29,001 - $32,715
-761 Reduced 3.4%
21,645 $814,000
Q2 2020

Aug 14, 2020

SELL
$37.87 - $43.58 $3,029 - $3,486
-80 Reduced 0.36%
22,406 $913,000
Q1 2020

May 06, 2020

BUY
$32.47 - $48.83 $47,893 - $72,024
1,475 Added 7.02%
22,486 $852,000
Q4 2019

Feb 13, 2020

SELL
$42.0 - $48.25 $497,238 - $571,231
-11,839 Reduced 36.04%
21,011 $987,000
Q3 2019

Nov 13, 2019

SELL
$40.46 - $43.52 $63,724 - $68,544
-1,575 Reduced 4.58%
32,850 $1.4 Million
Q2 2019

Aug 16, 2019

SELL
$39.4 - $42.7 $23,364 - $25,321
-593 Reduced 1.69%
34,425 $1.38 Million
Q1 2019

Apr 12, 2019

BUY
$38.57 - $42.69 $5,361 - $5,933
139 Added 0.4%
35,018 $1.46 Million
Q4 2018

Jan 30, 2019

BUY
$37.8 - $42.69 $105,839 - $119,532
2,800 Added 8.73%
34,879 $1.33 Million
Q3 2018

Oct 15, 2018

BUY
$39.75 - $42.69 $330,720 - $355,180
8,320 Added 35.02%
32,079 $1.29 Million
Q1 2018

Apr 20, 2018

SELL
$36.18 - $40.15 $56,585 - $62,794
-1,564 Reduced 6.18%
23,759 $928,000
Q4 2017

Jan 22, 2018

SELL
$35.34 - $41.9 $31,275 - $37,081
-885 Reduced 3.38%
25,323 $898,000
Q3 2017

Oct 25, 2017

BUY
$39.44 - $41.55 $1.03 Million - $1.09 Million
26,208
26,208 $1.06 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.